✦ LIBER ✦

DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma

✍ Scribed by Álisson Marques de Miranda Cabral Gontijo; João Paulo de Castro Marcondes; Flávia Nunes Elias; Maria Luiza Cotrim Sartor de Oliveira; Rodrigo Otávio Alves de Lima; Daisy Maria Favero Salvadori; João Lauro Viana de Camargo

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 149 KB
Volume: 40
Category: Article
ISSN: 0893-6692
DOI: 10.1002/em.10109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of urothelial carcinoma with trip

A case of urothelial carcinoma with triple variants featuring nested, plasmacytoid, and lipoid cell morphology

✍ Keiji Shimada; Mitsutoshi Nakamura; Noboru Konishi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

## Abstract We present very rare variants of urothelial carcinoma featuring nested, plasmacytoid, and lipoid cell morphology in an 80‐year‐old female who was admitted to our hospital with mictritional pain and bilateral hydronephrosis. Abdominal computed tomography showed diffuse thickening of the

A multicolor fluorescence in situ hybrid

A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non–muscle-invasive urothelial cell carcinoma : A prospective study

✍ Ana B. Galván; Marta Salido; Blanca Espinet; José Placer; Lara Pijuan; Núria Jua 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 170 KB 👁 1 views

A phase II trial of R115777, an oral far

A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma

✍ Jonathan E. Rosenberg; Hans von der Maase; John D. Seigne; Jozef Mardiak; David 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

A phase II study of gemcitabine and doce

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or ≥ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

A-FABP, a candidate progression marker o

A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells

✍ Guillaume Boiteux; Isabelle Lascombe; Emmanuelle Roche; Marie-Laure Plissonnier; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 398 KB 👁 1 views

## Abstract Superficial pT1 bladder tumors are characterized by a high risk of recurrence and progression in grade and stage. Few studies provided evidence that loss of adipocyte‐fatty acid binding protein (A‐FABP) expression was associated with bladder cancer progression. A‐FABP is a lipid binding

DNA adducts in urothelial cells: Relatio

DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke

✍ Paolo Vineis; Glenn Talaska; Christian Malaveille; Helmut Bartsch; Tiziana Marto 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 2 views

Markers of exposure to polycyclic aromatic hydrocarbons (urinary I -hydroxypyrene-glucuronide) and aromatic arnines (4-aminobiphenyl-hemoglobin adducts), as well as urinary mutagenicity, were measured in 47 healthy smokers and 50 nonsmokers. DNA adducts were determined by P32-postlabeling in the exf